期刊文献+

食管癌术后并发症危险因素的Logistic分析及护理干预 被引量:20

Logistic regressive analysis of risk factors for postoperative complications and nursing intervention of esophageal carcinoma
暂未订购
导出
摘要 目的探讨食管癌术后并发症的常见类型和危险因素,为并发症的预防提供有效的护理对策。方法回顾性分析142例经手术治疗的食管癌患者,统计并发症发生的类型和发生率,对危险因素采用单因素Х^2检验和多因素Logistic回归分析。结果食管癌术后并发症发生率为32.4%,其中肺部并发症发生率为21.1%。结果显示接受放化疗(OR=1.438,95%CI1.231~1.690)、吸烟(OR=2.152,95%CI1.756-2.637)、烟龄(OR=2.447,95%CI1.683~3.558)、营养不良(OR=1.930,95%CI1.756~2.121)、合并肺部疾病(OR=2.251,95%CI1.850—2.739)和手术时间(OR=2.550,95%CI1.989~3.269)是并发症发生的危险因素(P〈0.05),而胸腹腔镜手术(OR=0.436,95%CI0.313~0.607)是并发症发生的保护因素(P〈0.05)。结论食管癌术后并发症的发生率很高,并且与患者的基础特征、手术、营养等多种因素有关,必须根据相关危险因素实施有针对性的护理工作,以彻底地预防和降低并发症的发生。 Objective To explore the categories of postoperative complications and risk factors of esophageal carcinoma, which may help establish effective nursing strategies for prevention of complications. Methods We did a retrospective analysis on the clinical profiles of 142 patients with esophageal carcinoma who underwent surgery. This entailed the determination of the categories, the incidence of postoperative complications and the risk factors via uni- variate Х^2 tests and multivariate Logistic regression analysis. Results The incidence of postoperative complications was 32.4%, of which the incidence of pulmonary complication was 21.1%. Multivariate analysis showed that radio- chemical therapy (OR=1.438, 95%CI: 1.231-1.690), smoking (OR=2.152, 95%CI: 1.756-2.637), the number of years of smoking (OR=2.447, 95%CI: 1.683-3.558), malnutrition (OR=1.930, 95%C1: 1.756-2.121), complication with pul- monary diseases (OR=2.251, 95%CI: 1.850-2.739) and the duration of operation (OR=2.550, 95%CI: 1.989-3.269) were the risk factors for complications. Whereas the chest laparoscopic surgery was a protective factor (OR=0.436, 95%CI: 0.313-0.607). Conclusion The incidence of postoperative complications is high in patients with esophageal carcinoma and is related to patient's characteristics, the mode of surgery and nutritional status. This warrants targeted nursing strategies in accordance with the risk factors, which may achieve a thorough prevention and reduction of the incidence of postoperative complications.
出处 《中国药物与临床》 CAS 2014年第3期300-302,共3页 Chinese Remedies & Clinics
基金 浙江省医学会临床科研基金(2012ZYC-A85)
关键词 食管肿瘤 手术后并发症 吻合口瘘 肺部感染 Esophageal neoplasms Postoperative complications Anastomotic fistula Pulmonary infection
  • 相关文献

参考文献4

二级参考文献15

  • 1周明,王远东,韩国栋,陈贵全,李洪胜.促红细胞生成素在食管癌患者中的应用[J].岭南现代临床外科,2004,4(2):131-132. 被引量:12
  • 2尧永华,宁雪,张平,谭平,郑映菲.开胸术后肋间神经冷冻镇痛与患者自控硬膜外镇痛的比较[J].第一军医大学学报,2005,25(4):469-470. 被引量:4
  • 3Benoit Mesurolle,Salah Dine Qanadli,Myrianm Merad.Unusual Badiologic Findings in the thrax after radiation therapy[J].Radiographics,2000,20(1):67-81.
  • 4Malhotra SK,Kaur RP,Gupta NM,et al.Incidence and types of arrhythmias after mediastinal manipulation during transhiatal esophagectomy[J].Ann Thorac Surg,2006,82(1):298-302.
  • 5Atkins BZ,Shah AS,Hutcheson KA,et al.Reducing hospital morbidity and mortality following esophagectomy[J].Ann Thorac Surg,2004,78(4):1170-1176.
  • 6Miller KB,Kaplan B,Shepherd RW.Severe tracheal compression causing respiratory failure after transhiatal esophagectomy[J].Ann Thorac Surg,2010,89(3):977-979.
  • 7Tabatabai A,Hashemi M,Mohajeri G,et al.Incidence and risk factors predisposing anastomotic leak after transhiatal esophagectomy[J].Ann Thorac Med,2009,4(4):197-200.
  • 8Avendano CE,Flume PA,Silvestri GA,et al.Pulmonary complications after esophagectomy[J].Ann Thorac Surg,2002,73(3):922-926.
  • 9Ferguson MK,Durkin AE.Preoperative prediction of ther isk of pulmonary complications after esophagectomy for cancer[J].Thorac Cardiovasc Surg,2002,123(4):661-669.
  • 10Lee HK,Vaporciyan AA,Cox JD,et al.Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinima:correlation with pulmonary dosevolume histogram parameters[J].Int J Radiat Oncol Biol Phys,2003,57(5):1317-1322.

共引文献29

同被引文献155

  • 1苏鹏飞,李伟,段东奎.大剂量氨溴索在肺叶切除围术期对肺功能的保护作用[J].中国老年学杂志,2014,34(8):2124-2125. 被引量:18
  • 2刘丽霞,胡振杰,赵钗.食管癌手术前肺功能试验与术后急性呼吸窘迫综合征的相关性[J].癌症,2006,25(3):335-338. 被引量:21
  • 3刘君,崔飞,何建行,陈秋年.大剂量沐舒坦在微创胸外科术后的临床应用效果[J].实用医学杂志,2006,22(16):1930-1931. 被引量:30
  • 4Globocan2012:estimatedcancerincidence,mortalityandprevalenceworldwidein2012[EB/OL].[2014-06-03].http://globocan.iarc.fr/Default.aspx.
  • 5Non-smallcelllungcancerVersionI[EB/OL].[2014-07-18].http://www.nccn.org/patients.
  • 6SmetanaGW.Postoperativepulmonarycomplications:Anupdateonriskassessmentandreduction[J].CleveClinJMed,2009,76(Suppl4):S60-S65.
  • 7ShanderA,FleisherLA,BariePS,etal.Clinicalandeconomicburdenofpostoperativepulmonarycomplications:Patientsafetysummitondefinition,risk-reducinginterventions,andpreventivestrategies[J].CritCareMed,2011,39(9):2163-2172.
  • 8YoderMA,SharmaS.Perioperativepulmonarymanagement[EB/OL].[2014-08-09].http://medicine.medscape.com/284983-overview.
  • 9FerreyraG,LongY,RanieriVM.Respiratorycomplicationsaftermajorsurgery[J].CurrOpinCritCare,2009,15(4):342-348.
  • 10LiQ,YaoG,ZhuX.High-doseambroxolreducespulmonarycomplicationsinpatientswithacutecervicalspinalcordinjuryaftersurgery[J].NeurocritCare,2012,16(2):267-272.

引证文献20

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部